Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB-STBA for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 66 adverse event reports in the FDA FAERS database where USTEKINUMAB-STBA was used for Psoriasis.

Most Reported Side Effects for USTEKINUMAB-STBA

Side Effect Reports % Deaths Hosp.
Intentional product use issue 46 25.0% 2 6
Off label use 43 23.4% 3 7
Intentional dose omission 21 11.4% 1 9
Crohn's disease 20 10.9% 1 5
Death 15 8.2% 15 2
Haematochezia 13 7.1% 0 3
Condition aggravated 12 6.5% 0 3
Diarrhoea 10 5.4% 0 2
Colitis ulcerative 8 4.4% 0 1
Psoriasis 8 4.4% 0 0
Abdominal pain 6 3.3% 0 3
Frequent bowel movements 6 3.3% 0 1
Surgery 6 3.3% 0 2
Symptom recurrence 6 3.3% 0 0
Drug dose omission by device 5 2.7% 0 0

Other Indications for USTEKINUMAB-STBA

Crohn's disease (79) Colitis ulcerative (28) Product used for unknown indication (13) Psoriatic arthropathy (6)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

USTEKINUMAB-STBA Full Profile All Psoriasis Drugs USTEKINUMAB-STBA Demographics USTEKINUMAB-STBA Timeline